Titre:
  • Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer.
Auteur:Bergh, Jonas; Mariani, Gabriella; Cardoso, Fatima; Liljegren, A.; Awada, Ahmad; Vigano, L.; Huang, Xing; Verkh, L.; Kern, Kenneth A; Giorgetti, C.; Gianni, Luca
Informations sur la publication:Breast, 21, 4, page (507-513)
Statut de publication:Publié, 2012-08
Sujet CREF:Cancérologie
Mots-clés:Advanced breast cancer
Docetaxel
Sunitinib
Tyrosine kinase inhibitor
MeSH keywords:Adult
Aged
Antineoplastic Agents -- administration & dosage -- adverse effects -- pharmacokinetics
Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism
Carcinoma, Ductal, Breast -- drug therapy -- metabolism
Carcinoma, Lobular -- drug therapy -- metabolism
Drug Administration Schedule
Drug Interactions
Feasibility Studies
Female
Humans
Indoles -- administration & dosage -- adverse effects -- pharmacokinetics
Middle Aged
Neoplasm Recurrence, Local -- drug therapy
Pyrroles -- administration & dosage -- adverse effects -- pharmacokinetics
Receptor, erbB-2 -- metabolism
Taxoids -- administration & dosage -- adverse effects -- pharmacokinetics
Treatment Outcome
Note générale:Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0960-9776
info:doi/10.1016/j.breast.2012.01.012
info:pii/S0960-9776(12)00018-5
info:scp/84863874195
info:pmid/22336056